<DOC>
	<DOCNO>NCT00300339</DOCNO>
	<brief_summary>To investigate patient suffer intermittent claudication due Fontaine stage II PAD whether 24-week treatment SL650472 OD top clopidogrel may result improvement walking capacity , compare three dos SL650472 placebo , calibrate effect versus cilostazol</brief_summary>
	<brief_title>Mixed Antagonist Serotonin Claudication Optimal Therapy</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Intermittent Claudication</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>1 . Patient stable symptom intermittent claudication low extremity , secondary chronic occlusive arterial disease atherosclerosis origin ( symptoms present 6 month longer significantly change within past 3 month ) ; 2 . ICD 30 200 screening constant workload treadmill test 3 . Dopplermeasured pretreadmill ABI 0.90 low 10 minute rest , patient ABI great 1.3 ( noncompressible artery ) , ToeBrachial Index ( TBI ) less 0.7 . 1 . Age 40 year and/or onset symptom PAD age 40 year ; 2 . Nonatherosclerotic vascular disease ( e.g . Buerger 's disease , popliteal entrapment syndrome ) ; 3 . Limbthreatening ( grade III IV ) chronic limb ischemia , manifest ischemic rest pain , ulceration , gangrene . 4 . Patients history malignant proliferate breast disease .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2008</verification_date>
</DOC>